Patents by Inventor Aurelie Mousnier

Aurelie Mousnier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of quinoline derivatives with anti-integrase effect and applications thereof
    Patent number: 7479497
    Abstract: The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: January 20, 2009
    Assignees: Bioalliance Pharma SA, Institut Gustave Roussy, Centre National de la Recherche Scientifique (C.N.R.S.), Inserm, Universite de Paris 11- Paris Sud
    Inventors: Aurélie Mousnier, Catherine Dargemont, Sabine Bonnenfant, Hervé Leh, Jean-François Mouscadet, Fatima Zouhiri, Jean D'Angelo, Didier Desmaele
  • Use of quinoline derivatives with anti-integrase effect and applications thereof
    Publication number: 20050261336
    Abstract: The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
    Type: Application
    Filed: May 15, 2003
    Publication date: November 24, 2005
    Inventors: Aurelie Mousnier, Catherine Dargemont, Sabine Bonnenfant, Herve Leh, Jean-Francois Mouscadet, Catherine Dargemont, Sabine Bonnenfant, Herve Leh, Jean-Francois Mouscadet, Fatima Zouhiri, Jean D'Angelo, Didier Desmaele